Insider Transactions in Q4 2025 at Cidara Therapeutics, Inc. (CDTX)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2025
|
Nicole Negar Davarpanah Chief Medical Officer |
SELL
Bona fide gift
|
Direct |
450
-2.11%
|
-
|
|
Dec 22
2025
|
Jeffrey Stein President & CEO |
SELL
Bona fide gift
|
Indirect |
5,425
-7.69%
|
-
|
|
Dec 19
2025
|
Jeffrey Stein President & CEO |
BUY
Bona fide gift
|
Indirect |
10,638
+13.11%
|
-
|
|
Dec 19
2025
|
Jeffrey Stein President & CEO |
SELL
Bona fide gift
|
Direct |
10,638
-50.82%
|
-
|
|
Dec 17
2025
|
Jeffrey Stein President & CEO |
BUY
Bona fide gift
|
Indirect |
2,244
+3.61%
|
-
|
|
Dec 17
2025
|
Jeffrey Stein President & CEO |
SELL
Bona fide gift
|
Direct |
2,244
-9.7%
|
-
|
|
Dec 10
2025
|
Jeffrey Stein President & CEO |
BUY
Bona fide gift
|
Indirect |
33,072
+36.45%
|
-
|
|
Dec 10
2025
|
Jeffrey Stein President & CEO |
SELL
Bona fide gift
|
Direct |
33,072
-58.85%
|
-
|
|
Dec 10
2025
|
Shane Ward COO & CLO |
SELL
Open market or private sale
|
Direct |
9,959
-28.46%
|
$2,190,980
$220.08 P/Share
|
|
Dec 10
2025
|
Shane Ward COO & CLO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,959
+13.4%
|
$179,262
$18.43 P/Share
|
|
Dec 10
2025
|
Shane Ward COO & CLO |
SELL
Payment of exercise price or tax liability
|
Direct |
15,041
-37.91%
|
$3,293,979
$219.6 P/Share
|
|
Dec 10
2025
|
Frank Karbe Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,290
-12.6%
|
$1,596,510
$219.6 P/Share
|
|
Dec 10
2025
|
Jeffrey Stein President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,285
-3.91%
|
$500,415
$219.6 P/Share
|
|
Dec 10
2025
|
Nicole Negar Davarpanah Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,332
-32.68%
|
$2,262,708
$219.6 P/Share
|